The Executive Playbook, Graded

Core executive health programs at named providers charge about $8,000 to $25,000 a year, with concierge tiers above that range.^[1] For that money you get one accountable physician, a broad blood panel, body composition and bone measurement, cardiac imaging, guideline cancer screening, and an annual day where all of it happens at once, with a specialist down the hall if anything turns up.

The honest verdict: the parts of these programs with the strongest evidence behind them are also the cheapest parts, and most of them are available free or close to it. Measured fitness and the training that follows from it, coronary calcium scoring tied to lipid management, guideline cancer screening, metabolic labs, and DEXA body composition and bone measurement carry the evidence. The expensive detection layer stacked on top, whole-genome sequencing, annual whole-body MRI, and multi-cancer blood tests, is where the longevity-branded programs differentiate themselves, and it is where the outcome evidence is thinnest.

One line separates this market in two. The hospital programs (Mayo Clinic, Cleveland Clinic, Cooper Clinic) sell guideline medicine, delivered efficiently, in a single day. The longevity-branded programs (Fountain Life, Human Longevity, Biograph) sell additional detection on top of the same guideline core.^[1]

And the two most evidence-dense offerings in the entire set cost the least. Cooper Clinic's exam, reported from about $2,500, is built around a measured fitness test backed by fifty years of outcome data. Peter Attia's published protocol, the framework in his book Outlive, is free to read and mostly free to run. Everything above those two price points buys consolidation, speed, escalation, and accountability. It does not buy better evidence.

Fountain Life's top tier keeps getting more expensive. APEX has carried three price points in under two years: $19,500 in February 2025, $21,500 in July 2025, and $23,500 in October 2026. That is roughly $2,000 a year of price drift on the flagship tier, and it is the best-documented price history in this market: the current price is published, and each earlier point is on the record through reporting (Keep Health for the $19,500 point in February 2025, Bloomberg via FoundersToday for the $21,500 point in July 2025).

Half this market does not publish prices at all. Human Longevity, Fountain Life, and Biograph publish ladders. Mayo, Cleveland Clinic, and Cooper Clinic do not, and Attia's practice has no published fee at all. Where a price in this piece is labeled reported, treat it as a planning figure, not a quote.

[1] Hospital-based programs (Mayo Clinic, Cleveland Clinic, Cooper Clinic) sell fee-for-service exams rather than annual memberships, and their prices fall below the membership range in the headline. Their figures are reported, not published. Range and footnote checked October 18, 2026.

Six programs, one union of components. Eight components appear in at least five of the six: a dedicated physician who owns the day, a broad blood panel, DEXA body composition and bone measurement, cardiac imaging, guideline cancer screening, nutrition and exercise counseling, same-system specialist escalation, and an annual cadence with results compared year over year.

The table below grades the components, not the brands. It has 20 rows: 7 sit among the strongest evidence in the set, 4 in the middle of the table, and 9 among the weakest. A note on how to read the evidence column: the screening grades in this table are built from the underlying studies, protocol grades are still being built, and rows awaiting a graded record say so. Where the research behind this piece placed a component among the strongest or weakest in the set, the table says that in plain language. Five rows, the screening components, already carry letter grades from graded records: the calcium score, CCTA, and whole-body MRI rows link to their graded pages, and the DEXA and CGM rows carry their grades while their pages are built. The remaining rows say "Graded record in progress" until their records land.

The detection layer is not an abstraction: Cenegenics lists Cleerly AI CCTA and Prenuvo whole-body MRI among its own diagnostic partners, so two of the services graded in our screening review (CCTA with AI plaque analysis, C-; whole-body MRI, D+) are literally part of what paid programs sell.

Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.

The graded core of every program above separates cleanly from the membership. Here is that core at three budget levels. Each level keeps the components from the strongest rows of the contents table and leaves the weakest rows out.

Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.

The free version above is real, and it is most of the evidence. Here is what it does not include, stated as plainly as the grading.

Escalation inside one system. When a Mayo or Cleveland Clinic scan finds something, the specialist appointment happens inside the same institution, often inside the same visit window. When your self-assembled calcium score finds something, you book your own cardiology referral and wait. That gap, a finding becoming an appointment without the patient project-managing it, is the single most defensible thing the memberships sell.

One physician who owns the day and the follow-up. The common core starts with a dedicated physician for a reason. In the paid programs, one clinician holds your history, your results, and your action plan, and at the concierge tiers that clinician is reachable all year. Human Longevity's entry tier shows the boundary honestly: at $8,000, a longevity clinician reviews your results with you directly, with personalized insights and a clear action plan. What the tier does not include is Human Longevity managing what happens next: the ongoing follow-up and continuing management are what the tiers above it add.

Logistics and time. A 1 to 3 day itinerary, coordinated scheduling, results in a day or two, records kept and compared year over year. A self-assembled version of the same core takes separate appointments spread across months, and most people never finish assembling it. The membership is, in part, a payment against your own procrastination, and for the executives these programs target, that is not a trivial purchase.

Accountability. Quarterly blood panels with a coach review, a named coordinator, a re-test already on the calendar. The free protocol has the same training prescription and nobody checking whether Tuesday happened.

What the money does not buy is better evidence. The strongest components are identical in the free version and the $23,500 version, because evidence does not have a tier. The additional detection the top tiers sell may prove valuable as trials complete, and our grades will move if it does. Today, paying more buys more testing, more access, and more follow-through. It buys certainty of scheduling. It does not buy certainty of outcome.

How we built this. Every program above was researched from a minimum of three independent sources, including the program's own published material, in October 2026. Program contents are described from operator materials and named third-party reporting. Company-reported outcome and detection figures are labeled as company-reported wherever they appear.

Pricing discipline. A price prints as published only when the operator states it. Everything else prints as reported, with the source type and date, and reported figures are planning estimates rather than quotes. Prices in this market move: Fountain Life's top tier has moved three times in under two years. We re-verify every price and tier on a quarterly cycle, and the piece carries its check date so a stale figure is visible as stale.

Grading status. Letter grades in Longevity Lab Report attach to graded records: today, the ingredient library and the first screening records. Coronary calcium scoring (B), DEXA body composition (B), CCTA with AI plaque analysis (C-), CGM for people without diabetes (C-), and whole-body MRI (D+) are graded; the calcium score, CCTA, and whole-body MRI grades link to their screening pages from the contents table, and the DEXA and CGM grades render without links until their pages exist. The protocol grades behind the remaining rows are in progress and land as the underlying records are graded; when a row gains a grade, the row links to that record. Until then, rows carry the evidence assessment from the research itself, labeled as shown.

Last reviewed: October 18, 2026. First edition. What changed: initial publication.

One more thing, once a week. Every Thursday, Longevity Lab Report sends the week's longevity and biotech news: biotech news, expert moves, what is working, and new supplements and peptides, in plain English and linked to the grades. When a program above changes its price, or a grade in the contents table lands or moves, Thursday is where it is reported.